Charlien Berghen

6PUBLICATIONS
26CO-AUTHORS
Radiation therapyFood properties (incl. characteristics and health benefits)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 17, 2025
Stereotactic Body Radiotherapy for Extracranial Oligometastatic Renal Cell Carcinoma: State of the Art and Future Perspectives.

Sander Vandaele, Maarten Albersen, Benoit Beuselinck

|Dec 09, 2023
The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects.

Hans Van der Eecken, Steven Joniau, Charlien Berghen

|Aug 23, 2020
Oncological Outcomes of Metastasis-Directed Therapy in Oligorecurrent Prostate Cancer Patients Following Radical Prostatectomy.

Gaëtan Devos, Charlien Berghen, Henri Van Eecke

|Jul 16, 2020
Long- versus short-term androgen deprivation therapy with high-dose radiotherapy for biochemical failure after radical prostatectomy: a randomized controlled trial.

Charlien Berghen, Steven Joniau, Annouschka Laenen

|Jan 26, 2019
Readressing the rationale of irradiation in stage I seminoma guidelines: a critical essay.

Charlien Berghen, Maarten Albersen, Pierre Blanchard

|Dec 15, 2018
Benefits of Elective Para-Aortic Radiotherapy for pN1 Prostate Cancer Using Arc Therapy (Intensity-Modulated or Volumetric Modulated Arc Therapy): Protocol for a Nonrandomized Phase II Trial.

Cédric Draulans, Steven Joniau, Valérie Fonteyne

Pageof 1

Frequent Collaborators

3 joint publications

Steven Joniau

2 joint publications

Piet Ost

1 joint publications

Cédric Draulans

1 joint publications

Valérie Fonteyne